Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Chaumais MC"'
Autor:
Tu L, De Man FS, Girerd B, Huertas A, Chaumais MC, Lecerf F, François C, Perros F, Dorfmüller P, Fadel E, Montani D, Eddahibi S, Humbert M, Guignabert C, Tu, Ly, De Man, Frances S, Girerd, Barbara, Huertas, Alice, Chaumais, Marie-Camille, Lecerf, Florence
Publikováno v:
American Journal of Respiratory & Critical Care Medicine; 10/1/2012, Vol. 186 Issue 7, p666-676, 11p
Publikováno v:
European Journal of Hospital Pharmacy : Science and Practice; 2018, Vol. 25 Issue: Supplement 1 pA244-A244, 1p
Autor:
Jambon-Barbara C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Hlavaty A; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Bernardeau C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France., Bouvaist H; Cardiology Unit, Grenoble Alpes University Hospital, Grenoble, France., Chaumais MC; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Pharmacy, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Faculty of Pharmacy, Université Paris-Saclay, Saclay, France., Humbert M; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France., Montani D; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France., Cracowski JL; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France., Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France.; Grenoble Alpes University Hospital, Clinical Pharmacology Department INSERM CIC1406, Grenoble, France.
Publikováno v:
ERJ open research [ERJ Open Res] 2024 Aug 12; Vol. 10 (4). Date of Electronic Publication: 2024 Aug 12 (Print Publication: 2024).
Autor:
Le Bozec A; Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Saclay, Service de Pharmacie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Pharmacie, Département de Pharmacie Clinique, Université Paris Saclay, Orsay, France., Korb-Savoldelli V; Université Paris Saclay, Faculté de Pharmacie, Département de Pharmacie Clinique, Université Paris Saclay, Orsay, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Service de Pharmacie, Hôpital Européen Georges Pompidou, Paris, France., Boiteau C; Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Saclay, Service de Pharmacie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Dechartres A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), CIC-1421, Paris, France., Al Kahf S; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Sitbon O; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Montani D; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Jaïs X; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Guignabert C; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France., Humbert M; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Savale L; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et soins intensifs, centre de référence de l'hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Chaumais MC; Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Saclay, Service de Pharmacie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France mcamillechaumais@gmail.com.; Université Paris-Saclay, Inserm, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de Pharmacie, Département de Pharmacie Clinique, Université Paris Saclay, Orsay, France.
Publikováno v:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2024 Jul 03; Vol. 33 (173). Date of Electronic Publication: 2024 Jul 03 (Print Publication: 2024).
Autor:
Ribeuz HL; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Willer AS; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Chevalier B; Paris Cité University, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris, France., Sancho M; Department of Physiology and.; Department of Pharmacology, University of Vermont, Burlington, Vermont.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Masson B; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Eyries M; Genetics Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Jung V; INSERM US24/CNRS UAR3633, Proteomic Platform Necker, Université Paris Cité-Federative Research Structure Necker, Paris, France., Guerrera IC; INSERM US24/CNRS UAR3633, Proteomic Platform Necker, Université Paris Cité-Federative Research Structure Necker, Paris, France., Dutheil M; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Jekmek KE; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Laubry L; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Carpentier G; Gly-CRRET Research Unit 4397, Paris-Est Créteil University, Créteil, France., Perez-Vizcaino F; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain., Tu L; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Guignabert C; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Chaumais MC; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Paris-Saclay University, Faculty of Pharmacy, Orsay, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Péchoux C; Paris-Saclay University, INRAE, AgroparisTech, GABI, Jouy-en-Josas, France., Humbert M; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Hinzpeter A; Paris Cité University, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris, France., Mercier O; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, Le Plessis-Robinson, France., Capuano V; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France., Montani D; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.; Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Antigny F; Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.
Publikováno v:
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2024 Jul; Vol. 71 (1), pp. 95-109.
Autor:
Grynblat J; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France.; These authors contributed equally to this work., Khouri C; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.; Pharmacovigilance Unit and Clinical Pharmacology Department, Grenoble Alpes University Hospital, Grenoble, France.; These authors contributed equally to this work., Hlavaty A; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.; Pharmacovigilance Unit and Clinical Pharmacology Department, Grenoble Alpes University Hospital, Grenoble, France., Jaïs X; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Savale L; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Chaumais MC; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; School of Pharmacy, University of Paris-Saclay, Saclay, France.; AP-HP, Department of Pharmacy, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Kularatne M; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France.; Division of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, AB, Canada., Jevnikar M; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Boucly A; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Antigny F; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Perros F; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France.; CarMeN Laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Simonneau G; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Sitbon O; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Humbert M; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France., Montani D; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hôpital Marie Lannelongue, Le Plessis-Robinson, France david.montani@aphp.fr.; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; School of Medicine, University of Paris-Saclay, Le Kremlin-Bicêtre, France.
Publikováno v:
The European respiratory journal [Eur Respir J] 2024 Jun 28; Vol. 63 (6). Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).
Autor:
Mouillot P; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France., Favrolt N; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France., Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Clinical Pharmacology Department INSERM CIC1406, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France., Grandvuillemin A; Regional Pharmacovigilance Center, François Mitterrand Hospital, Dijon, France., Chaumais MC; Faculty of Pharmacy, Université Paris-Saclay, Orsay, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Pharmacy Department, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France., Schenesse D; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France., Seferian A; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Jais X; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Savale L; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Beltramo G; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France., Sitbon O; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Cracowski JL; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France., Humbert M; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Georges M; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France., Bonniaud P; Department of Pneumology and Intensive Care, Reference Center for Rare Lung Diseases, François Mitterrand Hospital, Dijon, France.; Faculty of Medicine, INSERM 1231, University of Burgundy, Dijon, France.; P. Bonniaud and D. Montani contributed equally., Montani D; INSERM UMR_S 999 'Pulmonary Hypertension: Pathophysiology and Novel Therapies', Hospital Marie Lannelongue, Le Plessis-Robinson, France.; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; AP-HP, Department of Pneumology and Intensive Care, Pulmonary Hypertension Reference Centre, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; P. Bonniaud and D. Montani contributed equally.
Publikováno v:
ERJ open research [ERJ Open Res] 2024 May 20; Vol. 10 (3). Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Autor:
Montani D; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France., Antigny F; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France., Jutant EM; CHU de Poitiers, Respiratory Department, INSERM CIC 1402, IS-ALIVE Research Group, University of Poitiers, Poitiers, France., Chaumais MC; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Pharmacy, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, Faculty of Pharmacy, Saclay, France., Le Ribeuz H; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France., Grynblat J; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France., Khouri C; Univ. Grenoble Alpes, HP2 Laboratory, Grenoble, France.; Grenoble Alpes University Hospital, Pharmacovigilance Unit, Grenoble, France., Humbert M; Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France.
Publikováno v:
ERJ open research [ERJ Open Res] 2023 Nov 13; Vol. 9 (6). Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).
Autor:
Renet S; Paris Saint-Joseph Hospital Group, Pharmacy Department, Paris, France; University of Paris Nanterre, Education and Training Research Center (ED 139 - EA 1589), Nanterre, France. Electronic address: srenet@ghpsj.fr., Chaumais MC; Paris-Sud University, Faculty of Pharmacy, Chatenay-Malabry, France; Bicêtre Hospital, Pharmacy Department, Le Kremlin-Bicêtre, France; Inserm UMR_S 999, Marie-Lannelongue Hospital, Le Plessis-Robinson, France., Gallant-Dewavrin M; HTaPFrance, Association of Patients, Caregivers and Lung Transplants, Paris, France., Jouet E; Research in Human, Social and Mental Health Laboratory, GHU Paris Psychiatrie & Neurosciences, Maison-Blanche, Paris, France; Education Ethics Health (EA7505), Tours University, Tours, France., Bezie Y; Paris Saint-Joseph Hospital Group, Pharmacy Department, Paris, France., Humbert M; Inserm UMR_S 999, Marie-Lannelongue Hospital, Le Plessis-Robinson, France; Paris-Saclay University, Paris, France; Kremlin-Bicêtre Hospital, Department of Respiratory and Intensive Care Medicine, Le Kremlin-Bicêtre, France., Rieutord A; Gustave-Roussy Cancer Campus, Pharmacy Department, Villejuif, France., Las Vergnas O; University of Paris Nanterre, Education and Training Research Center (ED 139 - EA 1589), Nanterre, France.
Publikováno v:
Annales pharmaceutiques francaises [Ann Pharm Fr] 2023 Jan; Vol. 81 (1), pp. 53-63. Date of Electronic Publication: 2022 Jun 20.
Autor:
Hlavaty A; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France., Roustit M; Clinical Pharmacology Department INSERM CIC1406, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University - Grenoble, France., Montani D; INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie, Centre de référence Maladie Rares de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Chaumais MC; INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; Faculté de Pharmacie, Université Paris-Saclay, Châtenay Malabry, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pharmacie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Guignabert C; INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Humbert M; INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue, Le Plessis-Robinson, France.; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie, Centre de référence Maladie Rares de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Cracowski JL; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University - Grenoble, France., Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.; Clinical Pharmacology Department INSERM CIC1406, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University - Grenoble, France.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Dec; Vol. 88 (12), pp. 5227-5237. Date of Electronic Publication: 2022 Jul 10.